DA Davidson raised the firm’s price target on Standex (SXI) to $224 from $222 and keeps a Buy rating on the shares after its Q2 earnings beat. It was another quarter of organic growth decline for the company, led again by Engraving, and the management’s comments suggest there could be one quarter left to go before flipping to positive, the analyst tells investors in a research note. The firm adds however that Amran/Narayan is providing strong M&A benefits and internal organic growth, leading the management to increase its FY28 EBITDA margin expectation to 23% or more from 19% or more.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXI:
- Standex International’s Earnings Call: Optimism Amid Challenges
- Standex International Sees Growth Amid Strategic Acquisitions
- Standex sees Q3 revenue “moderately to significantly” higher than Q2
- Standex reports Q4 adjusted EPS $1.91, consensus $1.67
- Standex International (SXI) Q2 Earnings Cheat Sheet